Table 1 Patient clinical factors influencing the prescribing choices of heart failure guideline-directed medicines
Percentage of respondents who only chose ‘Often’ or ‘Always’ | Total (n = 34) | Associate staff (n = 19) | Staff (n = 15) | p-value |
|---|---|---|---|---|
N (%) | N (%) | N (%) | ||
Loop diuretic | ||||
Age | 10 (29.4) | 5 (26.3) | 5 (33.3) | 0.718 |
Blood pressure | 22 (64.7) | 10 (52.6) | 12 (80.0) | 0.152 |
Gender | 2 (5.9) | 2 (10.5) | 0 (0.0) | 0.492 |
Heart rate | 12 (35.3) | 8 (42.1) | 4 (26.7) | 0.476 |
Liver function | 7 (20.6) | 5 (26.3) | 2 (13.3) | 0.426 |
Pulmonary function | 19 (55.9) | 14 (73.7) | 5 (33.3) | 0.036 |
Renal function | 30 (88.2) | 16 (84.2) | 14 (93.3) | 0.613 |
Serum potassium | 29 (85.3) | 15 (78.9) | 14 (93.3) | 0.355 |
Renin–angiotensin–aldosterone system inhibitor (RAAS) | ||||
Age | 12 (35.3) | 7 (36.8) | 5 (33.3) | 0.832 |
Blood pressure | 27 (79.4) | 13 (68.4) | 14 (93.3) | 0.104 |
Gender | 3 (8.8) | 3 (15.8) | 0 (0.0) | 0.238 |
Heart rate | 9 (26.5) | 7 (36.8) | 2 (13.3) | 0.240 |
Liver function | 7 (20.6) | 2 (10.5) | 5 (33.3) | 0.199 |
Pulmonary function | 11 (32.4) | 8 (42.1) | 3 (20.0) | 0.217 |
Renal function | 29 (85.3) | 15 (78.9) | 14 (93.3) | 0.355 |
Serum potassium | 30 (88.2) | 16 (84.2) | 14 (93.3) | 0.613 |
Beta-blocker | ||||
Age | 13 (38.2) | 9 (47.4) | 4 (26.7) | 0.296 |
Blood pressure | 28 (82.4) | 17 (89.5) | 11 (73.3) | 0.370 |
Gender | 10 (29.4) | 5 (26.3) | 5 (33.3) | 0.718 |
Heart rate | 30 (88.2) | 18 (94.7) | 12 (80.0) | 0.229 |
Liver function | 5 (14.7) | 4 (21.1) | 1 (6.7) | 0.355 |
Pulmonary function | 26 (76.5) | 15 (78.9) | 11 (73.3) | 1.000 |
Renal function | 5 (14.7) | 4 (21.1) | 1 (6.7) | 0.355 |
Serum potassium | 10 (29.4) | 7 (36.8) | 3 (20.0) | 0.451 |